Company Biodel Inc Nasdaq
Equities
US09064M2044
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 31/05/15 |
Founder | 60 | 07/12/03 | |
President | 57 | 01/03/23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 12/04/21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 18/12/22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 01/03/23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 03/11/19 |
Muffy Carter
LAW | General Counsel | 71 | 28/11/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 01/03/23 | |
Director/Board Member | 62 | 01/03/23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 31/05/15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,709,043 | 18,650,831 ( 90.06 %) | 7,760 ( 0.0375 %) | 90.06 % |
Company contact information
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Sector
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |